North America Cancer Diagnostics Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

North America Cancer Diagnostics Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024


  • Products Id :- DBMR37
  • |
  • Pages: 350
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

The North America cancer diagnostics market is accounted to reach USD 17.72 billion by 2024 from USD 7.59 billion in 2016, it is growing at a CAGR of 11.2% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are the technological advancement in the field of early detection of cancer and high investment in cancer research by North America.

The key market players for North America cancer diagnostics Market are listed below:

GE Healthcare

Siemens Healthcare GmbH

Hologic, Inc,

Becton, Dickinson & Company.

Thermo Fisher Scientific, Inc.

Illumina, Inc.

Roche Diagnostics,

Abbott Laboratories, Inc.

QIAGEN.

The market is further segmented into:

Type

Application

Technology

End User

Geography

The North America cancer diagnostics market is segmented on the basis of technology, application and geography. The North America cancer diagnostics market is segmented into 2 types, namely platform based and instrument based.

Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.

Based on application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Based on geography, the North America cancer diagnostics market is segmented into 11 geographical regions, such as,

U.S.,

Mexico,

Canada,

Covered in this report

The report covers the present scenario and the growth prospects of the North America Cancer Diagnostics Market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table Of Contents

1. Introduction

1.1. Objectives Of The Study

1.2. Market Definition

1.3. Overview Of North America Cancer Diagnostics Market

1.4. Currency And Pricing

1.5. Limitation

1.6. Markets Covered

2. Market Segmentation

2.1. Markets Covered

2.2. Geographic Scope

2.3. Years Considered For The Study

2.4. Currency And Pricing

2.5. Research Methodology

2.6. Primary Interviews With Key Opinion Leaders

2.7. Secondary Sources

2.8. Assumptions

3. Market Overview

3.1. Drivers

3.1.1. Growth Of Aging Population And Rising Prevalence Of Cancer

3.1.2. Government Initiatives For Funding And Awareness About Cancer

3.1.3. Key Players Focusing On Strategic Decisions To Gain Market Share

3.1.4. Increasing Prevelance Of Cancer

3.2. Restraints

3.2.1. Stringent Reulations Imposed By International And Local Authorities

3.2.2. Shortage Of Skilled And Trained Professionals

3.3. Opportunities

3.3.1. Nanotechnology: Forthcoming Revolution In Cancer Diagnosis

3.3.2. Artificial Intelligence And The Imminent Health Revolution

3.3.3. Growing Medical Tourism In Asia

3.4. Challenges

3.4.1. Increasing Rivalry Among The Competitors

3.4.2. Poor Access To Cancer Detection And High Treatment Cocts In Lower Income Countries

4. Premium Insights

5. Executive Summary

6. North America Cancer Diagnostics Market, By Technology

6.1. Overview

6.2. Platform Based

6.2.1. Polymerase Chain Reaction(Pcr)

6.2.2. In Situ Hybridization (Ish)

6.2.3. Immunohistochemistry(Ihc)

6.2.4. Next Generation Sequencing (Ngs)

6.2.5. Dna Microarrays

6.2.6. Flow Cytometry

6.3. Instrument Based

6.3.1. Imaging

6.3.1.1. Magentic Resonance Imaging (Mri)

6.3.1.2. Ct(Computed Tomography)

6.3.1.3. Positron Emission Tomography- Computed Tomography (Pet-Ct)

6.3.1.4. Mammography

6.3.1.5. Ultrasound

6.3.2. Biopsy

7. North America Cancer Diagnostics Market, By Application

7.1. Overview

7.2. Lung Cancer

7.3. Breast Cancer

7.4. Colorectal Cancer

7.5. Melanoma

7.6. Others

8. North America Cancer Diagnostics Market, By Geography

8.1. Overview

8.2. North America Cancer Diagnostics Market

8.2.1. U.S.Cancer Diagnostics Market

8.2.2. Canada Cancer Diagnostics Market

8.2.3. Mexico Cancer Diagnostics Market

9. North America Cancer Diagnostics Market, Company Landscape

9.1. Company Share Analysis: North America Cancer Diagnostics Imaging Market

9.2. Company Share Analysis: North America Cancer Diagnostics Platform Based Market

10. Company Profiles

10.1. C. R. Bard, Inc.

10.1.1. Company Overview

10.1.2. Revenue Analysis

10.1.3. Product Portfolio

10.1.4. Recent Developments

10.2. Illumina, Inc.

10.2.1. Company Overview

10.2.2. Revenue Analysis

10.2.3. Recent Developments

10.2.4. Product Portfolio

10.3. Qiagen

10.3.1. Company Overview

10.3.2. Revenue Analysis

10.3.3. Recent Developments

10.3.4. Product Portfolio

10.4. Abbott

10.4.1. Company Overview

10.4.2. Revenue Analysis

10.4.3. Recent Developments

10.4.4. Product Portfolio

10.5. Siemens Healthcare Gmbh

10.5.1. Company Overview

10.5.2. Revenue Analysis

10.5.3. Recent Developments

10.5.4. Product Portfolio

10.6. Agilent Technologies

10.6.1. Company Overview

10.6.2. Revenue Analysis

10.6.3. Product Portfolio

10.6.4. Recent Developments

10.7. Thermo Fisher Scientific Inc.

10.7.1. Company Overview

10.7.2. Revenue Analysis

10.7.3. Product Portfolio

10.7.4. Recent Developments

10.8. Becton, Dickinson And Company

10.8.1. Company Overview

10.8.2. Revenue Analysis

10.8.3. Product Portfolio

10.8.4. Recent Developments

10.9. Ge Healthcare

10.9.1. Company Overview

10.9.2. Revenue Analysis

10.9.3. Product Portfolio

10.9.4. Recent Developments

10.10. F. Hoffmann-La Roche Ltd

10.10.1. Company Overview

10.10.2. Revenue Analysis

10.10.3. Product Portfolio

10.10.4. Recent Developments

10.11. Hologic Inc.

10.11.1. Company Overview

10.11.2. Revenue Analysis

10.11.3. Recent Developments

10.11.4. Product Portfolio

10.12. Koninklijhe Philips N.V.

10.12.1. Company Overview

10.12.2. Revenue Analysis

10.12.3. Product Portfolio

10.12.4. Recent Developments

11. Related Reports

Figures List

Figure 1 North America Cancer Diagnostics Market Snapshot (2017)

Figure 2 North America Cancer Diagnostics Market, By Country (2016)

Figure 3 North America Cancer Diagnostics Market : By Country (2017)

Figure 4 North America Cancer Diagnostics Market By Country (2016 & 2024)

Figure 5 North America Cancer Diagnostics Market, By Technology (2017 & 2024)

Table List

Table 1 North America Cancer Diagnostics Market, By Country, 2015-2024 (Usd Million)

Table 2 North America Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 3 North America Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 4 North America Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 5 North America Instrument Based Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 6 North America Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 7 U.S.Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 8 U.S. Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 9 U.S. Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 10 U.S. Instrument Based Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 11 U.S. Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 12 Canada Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 13 Canada Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 14 Canada Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 15 Canada Instrument Based Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 16 Canada Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 17 Mexico Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 18 Mexico Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 19 Mexico Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 20 Mexico Instrument Based Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 21 Mexico Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

GE Healthcare

Siemens Healthcare GmbH

Hologic, Inc,

Becton, Dickinson & Company.

Thermo Fisher Scientific, Inc.

Illumina, Inc.

Roche Diagnostics,

Abbott Laboratories, Inc.

QIAGEN.

select a license
Single User License
USD 4200 INR 301518
Corporate User License
USD 5400 INR 387666

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com